← Open Payments lookup

KRISTIAN LUONG: Open Payments

NPI 1962076448 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$928 in 29 payments from 13 companies in 2025. Trend: 2023 $439 · 2024 $1,539 · 2025 $928

Food & beverage: $928
CompanyPaymentsAmount
Incyte Corporation3$292
Regeneron Healthcare Solutions, Inc.2$144
ABBVIE INC.5$82
Organon LLC5$74
Novartis Pharmaceuticals Corporation1$69
Lilly USA, LLC3$67
Janssen Biotech, Inc.3$58
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
LEO Pharma Inc.1$30
UCB, Inc.1$24

Products named: OPZELURA, LIBTAYO, RINVOQ, TREMFYA, EBGLYSS, DUPIXENT, SPEVIGO, ADBRY.

Industry payments across CA — which companies pay providers there.